Pathogen Immune Evasion Strategies Explained

Pathogens, such as viruses and bacteria, have developed sophisticated strategies to avoid being detected and eliminated by the host immune system. Understanding these evasion mechanisms is crucial in studying infectious diseases.

The question asks us to match specific immune evasion strategies employed by pathogens (Column X) with the corresponding pathogens (Column Y). Let's look at the strategies and their matched pathogens as provided in the correct answer.

Matching Pathogen Evasion Strategies

Let's break down each match:

• A - (i): Changing the antigen expressed on their surface matched with Influenza virus. Viruses like Influenza are famous for their ability to change the surface proteins (antigens) they display. This can happen through two main processes: antigenic drift (small mutations, covered in E) and antigenic shift (larger changes, often through gene reassortment). Both processes allow the virus to present new antigens that the host's existing antibodies and immune memory may not recognize, helping it evade the immune response. Influenza virus effectively uses this strategy.
• B - (iii): Increasing phagocytic activity of macrophage matched with Gram +ve bacteria. This pairing suggests that Gram +ve bacteria somehow cause macrophages to increase their phagocytic activity. While pathogens commonly *evade* phagocytosis (e.g., by producing capsules or interfering with the process), the provided match indicates a different interaction. Gram +ve bacteria do interact with macrophages, often triggering inflammatory responses. However, strategies aimed at *increasing* overall phagocytic activity are not typical bacterial evasion tactics; evasion involves *avoiding* being phagocytosed or surviving *within* the phagocyte. Based on the provided match, this is the pairing.
• C - (ii): Developing resistance to complement-mediated lysis matched with Neisseria. The complement system is a part of the innate immune response that can directly kill bacteria (lysis) or opsonize them for phagocytosis. Bacteria in the genus Neisseria, particularly pathogenic species like N. gonorrhoeae and N. meningitidis, are known to be able to resist lysis by the human complement system. They achieve this through various mechanisms, such as acquiring host complement regulatory proteins onto their surface. This allows them to survive in the bloodstream and tissues.
• D - (iv): Secreting proteases to inactivate antibodies matched with No bacteria. Some bacteria are known to secrete enzymes called proteases that can cleave and inactivate host antibodies, particularly IgA antibodies found on mucosal surfaces. Examples include certain species of Neisseria, Haemophilus, and Streptococcus. However, according to the provided match, none of the listed bacteria in column Y (specifically (iii) Gram +ve bacteria, (ii) Neisseria) employ this strategy. This pairing suggests that among the options provided, this specific evasion strategy is not adopted by a bacteria.
• E - (i): Allowing point mutations in surface epitopes resulting in antigenic drift matched with Influenza virus. Antigenic drift is a key mechanism used by Influenza viruses. It involves small, gradual changes in the genes that code for the virus's surface proteins (Hemagglutinin and Neuraminidase). These changes result from point mutations during viral replication. Over time, these accumulated mutations alter the surface epitopes so that antibodies generated against previous versions of the virus are less effective. This is why new influenza vaccines are needed regularly and is a specific type of strategy under the broader category of "changing the antigen expressed on their surface" (Strategy A).

Based on the provided matching pairs, the correct combination is A - (i), B - (iii), C - (ii), D - (iv), and E - (i).